18269-Ovarian Cancer-NA-1240

Ovarian Cancer

ENGOT-ov50 / INNOVATE-3: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant with Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer

  • Details

ClinicalTrials.gov ID: NCT03940196
Diagnosis Type: NA
USOR Number: 18269

  • Address

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.